Table 3 Patient outcome
Year | Author | Initial treatment method | Patients (n) | Median Number of stents/ sponges (range) | Median days treatment duration (range) | Successful closure rate (n) | Treatment related complications (n) | Majpr complications (n) | Esophago- tracheal fistula (n) | Surgical revision (n) | Stricture (n) | Time on ICU days | Median hospitalization in days (range) | In hospital mortality (n) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2013 | Brangewitz | EVT | 32 | 7 (5–28) | 23 (9–86) | 27 | 8 | 3 | 1 | 1 | 3 | - | 48.5 (21–122) (mean und range) | 5 |
SEMS | 39 | 3 (2–6) | 33 (9–132) | 21 | 8 | 6 | 0 | 3 | 11 | - | 41 (2–93) (mean und range) | 11 | ||
2013 | Schniewind | EVT | 17 | – | – | – | – | – | – | 0 | – | 26 ± 19 (mean + SD) | 57 ± 30 (mean und SD) | 2 |
SEMS | 12 | – | – | – | – | – | – | 2 | – | 38 ± 32 (mean + SD) | 62 ± 39 (mean + SD) | 5 | ||
2015 | Mennigen | EVT | 15 | 6.5 (1–18) | 26,5 (3–75) | 14 | 0 | 0 | 0 | 0 | – | – | 58 (23–106) | 1 |
SEMS | 30 | 1 (1–6) | 36 (1–156) | 19 | 1 | 3 | 1 | 4 | – | – | 53 (13–195) | 8 | ||
2016 | Hwang | EVT | 7 | 4.3 (2–10) | 27 (2–84) | 7 | 0 | 0 | – | 0 | – | – | 37.1 (13–128) | – |
SEMS | 11 | 1.6 (1–4) | 19.5 (5–21) | 7 | 6 | 5 | – | 3 | – | – | 87.3 (17–366) | – | ||
2018 | Berlth | EVT | 34 | 3 (1–9) | 12 (3–58) | 24 | 4 | – | 0 | 0 | 1 | Median 6 (0–60) | 37 (19–118) | 3 |
SEMS | 77 | 1 (1–3) | 27 (1–152) | 49 | 18 | – | 4 | 0 | 5 | Median 9 (0–295) | 38 (13–296) | 11 | ||
2021 | Eichelmann | EVT | 30 | 6 (1–25) | 23 (3–101) | 28 | – | – | – | – | 1 | Median 18 (4–107) | 47 (14–119) | 5 |
SEMS | 14 | 1 (1–3) | 44 (11–68) | 13 | – | – | – | – | 5 | Median 18 (8–38) | 34 (17–56) | 1 | ||
2021 | El Sourani | EVT | 13 | 5 (4–18) | 24.5 (8–80 | 12 | 0 | 4 | – | 5 | – | Median 38 (9–193) | 74 (9–193) | 5 |
SEMS | 7 | 1 (1–2) | 22 (3–31) | 6 | 2 | 2 | – | 1 | – | Median 20 (16–57) | 41 (22–123) | 1 |